SOLVENTUM CORPORATION Supplier Finance Program Obligation
SOLVENTUM CORPORATION (SOLV) had Supplier Finance Program Obligation of $1.00 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Liabilities › Accounts Payable and Accrued Liabilities
us-gaap:SupplierFinanceProgramObligation · last filed 2026-08-05
- 2026-06-30: Supplier Finance Program Obligation $1.00M.
- 2025-12-31: Supplier Finance Program Obligation $0.00.
| Period end | Supplier Finance Program Obligation |
|---|---|
| 2026-06-30 | $1.00M 10-Q · filed 2026-08-05 |
| 2025-12-31 | $0.00 10-Q · filed 2026-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |